Ganga Pharmaceuticals Ltd Balance Sheet: Consolidated Financial Analysis & Historical Data (15 Years)

Annual Results

Results Snapshot

Figures in Cr

Standalone - Balance Sheet Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Balance Sheet Analysis Highlights

Borrowings

YoY Growth in year ended Mar 2025 is 4.41% vs -25.68% in Mar 2024

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

Fixed Assets

YoY Growth in year ended Mar 2025 is 8.20% vs -4.69% in Mar 2024

Investments

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Current Assets

YoY Growth in year ended Mar 2025 is 19.48% vs 11.65% in Mar 2024

Compare Balance Sheet Results of Ganga Pharma.

Select Peers

Figures in Cr

Standalone - Balance Sheet Results

Change(INR)

Change(%)

No of Months

EQUITY AND LIABILITIES

Share Capital

4.84

4.00

0.84

21.00%

Share Warrants & Outstandings

Total Reserve

1.67

0.02

1.65

8,250.00%

Shareholder's Funds

7.13

4.02

3.11

77.36%

Minority Interest

0.00

0.00%

Long-Term Borrowings

0.23

0.18

0.05

27.78%

Secured Loans

0.00

0.00%

Unsecured Loans

0.23

0.18

0.05

27.78%

Deferred Tax Assets / Liabilities

0.01

-0.00

0.01

0.00%

Other Long Term Liabilities

0.00

0.00%

Long Term Trade Payables

0.00

0.00%

Long Term Provisions

0.00

0.00%

Total Non-Current Liabilities

0.24

0.77

-0.53

-68.83%

Current Liabilities

Trade Payables

0.28

3.22

-2.94

-91.30%

Other Current Liabilities

0.14

0.54

-0.40

-74.07%

Short Term Borrowings

1.19

5.32

-4.13

-77.63%

Short Term Provisions

0.00

0.04

-0.04

-100.00%

Total Current Liabilities

1.60

9.12

-7.52

-82.46%

Total Liabilities

8.97

13.91

-4.94

-35.51%

ASSETS

Non-Current Assets

0.00

0.00%

Gross Block

1.47

0.07

1.40

2,000.00%

Less: Accumulated Depreciation

0.80

0.05

0.75

1,500.00%

Less : Impairment of Assets

0.00

0.00%

Net Block

0.66

0.02

0.64

3,200.00%

Lease Adjustment

0.00

0.00%

Capital Work in Progress

0.00

0.00%

Intangible assets under development

0.00

0.00%

Pre-operative Expenses pending

0.00

0.00%

Assets in transit

0.00

0.00%

Non Current Investments

0.00

1.91

-1.91

-100.00%

Long Term Loans & Advances

0.00

0.59

-0.59

-100.00%

Other Non Current Assets

1.44

0.00

1.44

0.00%

Total Non-Current Assets

2.11

2.53

-0.42

-16.60%

Current Assets Loans & Advances

Current Investments

0.00

0.00%

Inventories

1.18

1.84

-0.66

-35.87%

Sundry Debtors

0.91

7.39

-6.48

-87.69%

Cash and Bank

0.30

0.05

0.25

500.00%

Other Current Assets

0.00

0.03

-0.03

-100.00%

Short Term Loans and Advances

4.47

2.08

2.39

114.90%

Total Current Assets

6.87

11.38

-4.51

-39.63%

Net Current Assets (Including Current Investments)

5.26

2.27

2.99

131.72%

Total Current Assets Excluding Current Investments

6.87

11.38

-4.51

-39.63%

Miscellaneous Expenses not written off

0.00

0.00%

Total Assets

8.97

13.91

-4.94

-35.51%

Contingent Liabilities

0.00

0.00%

Total Debt

1.42

6.09

-4.67

-76.68%

Book Value per share (adjusted)

13.46

1.01

12.45

1,232.67%

Annual - Borrowings

Borrowings 1.42 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 4.41% vs -25.68% in Mar 2024

Annual - Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets

Fixed Assets 0.66 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 8.20% vs -4.69% in Mar 2024

Annual - Investments

Investments 0.00 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Annual - Current Assets

Current Assets 6.87 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 19.48% vs 11.65% in Mar 2024